This is the Continuous Integration Build of FHIR (will be incorrect/inconsistent at times).
See the Directory of published versions
Oral Chemotherapy Example - Manufactured Product - Xeloda - includes a reference to a substance in ingredient element
{
"resourceType" : "Medication",
"id" : "medexample015",
"contained" : [{
"resourceType" : "Organization",
"id" : "mmanu",
"name" : "Medication Manufacturer"
},
{
"resourceType" : "Substance",
"id" : "sub04",
"instance" : false,
"code" : {
"concept" : {
"coding" : [{
"system" : "http://snomed.info/sct",
"code" : "386906001",
"display" : "Capecitabine (substance)"
}]
}
}
}],
"code" : {
"coding" : [{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "213293",
"display" : "capecitabine 500 MG Oral Tablet [Xeloda]"
}]
},
"marketingAuthorizationHolder" : {
"reference" : "#mmanu"
},
"doseForm" : {
"coding" : [{
"system" : "http://snomed.info/sct",
"code" : "385055001",
"display" : "Tablet (basic dose form)"
}]
},
"ingredient" : [{
"item" : {
"reference" : {
"reference" : "#sub04"
}
},
"strengthRatio" : {
"numerator" : {
"value" : 500,
"system" : "http://unitsofmeasure.org",
"code" : "mg"
},
"denominator" : {
"value" : 1,
"system" : "http://terminology.hl7.org/CodeSystem/v3-orderableDrugForm",
"code" : "TAB"
}
}
}],
"batch" : {
"lotNumber" : "9494788",
"expirationDate" : "2017-05-22"
}
}
Usage note: every effort has been made to ensure that the
examples are correct and useful, but they are not a normative part
of the specification.